Current Development of Virotherapy in Breast Cancer: A Brief Review
Breast cancer is the cancer with the greatest incidence in the world by 2020. This cancer has a high mortality rate, has the capability of metastasizing, and causes damage to important organs of the human body. Therefore, a lot of studies have been done to find the best therapy to overcome this prob...
Saved in:
| Main Authors: | Sasmana I., Putri P., Dewi N., Supadmanaba I., Wihandani D. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2024-12-01
|
| Series: | Acta Medica Bulgarica |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/amb-2024-0084 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experimental models for developing oncolytic virotherapy for metastatic prostate cancer
by: Ying-Cheng Chen, et al.
Published: (2025-07-01) -
Correction: Experimental models for developing oncolytic virotherapy for metastatic prostate cancer
by: Ying-Cheng Chen, et al.
Published: (2025-08-01) -
An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy
by: Muhammad Naveed, et al.
Published: (2024-11-01) -
Comparative safety and efficacy of oncolytic virotherapy for the treatment of individuals with malignancies: a systematic review, meta-analysis, and Bayesian network meta-analysisResearch in context
by: Poyee Lau, et al.
Published: (2025-08-01) -
A bibliometric analysis of oncolytic virotherapy combined with immunotherapy
by: Ting Zhang, et al.
Published: (2024-12-01)